Get the scoop on our progress and newsworthy events.

Cognivia-Narrow-Hero-2
News

Why Patient Retention Still Fails in Clinical Trials — And How Predictive Signals Can Help Ops Teams Anticipate Drop‑Out Earlier

Patient retention or patient engagement have become a main operational challenge in today’s clinical trials. Despite major investments…

Read More
cognivia signal launch
News

Introducing Cognivia Signal: Early-Warning Behavioral Risk Intelligence for Clinical Trials

Cognivia launches the world’s first early-warning behavioral risk intelligence dashboard—Cognivia Signal—empowering clinical teams to see what’s coming before…

Read More
News

New Study Validates Cognivia’s Approach to Reducing Noise in Pain and Mood Trials

New Publication in The Journal of Pain Demonstrates Scalable Method to Improve Measurement of Subjective Endpoints in Clinical Trials Mont-Saint-Guibert,…

Read More

There are currently no future events.
See our events archive for our previous event attendance.

Previous Events

Events

9th International Congress on Neuropathic Pain

NeuPSIG’s mission is to advance the understanding of mechanisms, assessment, prevention, and treatment of neuropathic pain. Event Date:…

Read More
Events

BIO International Convention

Event Date: June 16 – 19, 2025Event Location: Boston, MA, USAEvent Link

Read More
Events

Artificial Intelligence in Healthcare Summit

Business Research Intelligence Network’s AI in Healthcare Summit brings together decision-makers from hospitals, health systems, tech companies, investors…

Read More
Events

United States Association for the Study of Pain

Annual scientific meeting for advancing pain research and innovation to enhance care. Event Date: April 29 – May…

Read More

Understand patient differences in your next clinical trial

Increase your trial’s success rates and bring new therapies to patients faster.

Tell us about your clinical trial below, and our team will be in touch.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.